Impax Asset Management Group’s Charles River Laboratories CRL Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-1,115
| Closed | -$264K | – | 317 |
|
|
2023
Q4 | $264K | Sell |
1,115
-1,987
| -64% | -$470K | ﹤0.01% | 359 |
|
|
2023
Q3 | $608K | Sell |
3,102
-141
| -4% | -$27.6K | ﹤0.01% | 313 |
|
|
2023
Q2 | $682K | Sell |
3,243
-39
| -1% | -$8.2K | ﹤0.01% | 311 |
|
|
2023
Q1 | $662K | Buy |
3,282
+1,127
| +52% | +$227K | ﹤0.01% | 304 |
|
|
2022
Q4 | $470K | Buy |
+2,155
| New | +$470K | ﹤0.01% | 323 |
|
|
2022
Q3 | – | Sell |
-945
| Closed | -$202K | – | 397 |
|
|
2022
Q2 | $202K | Hold |
945
| – | – | ﹤0.01% | 384 |
|
|
2022
Q1 | $268K | Sell |
945
-5
| -0.5% | -$1.42K | ﹤0.01% | 387 |
|
|
2021
Q4 | $358K | Sell |
950
-26
| -3% | -$9.8K | ﹤0.01% | 363 |
|
|
2021
Q3 | $403K | Hold |
976
| – | – | ﹤0.01% | 342 |
|
|
2021
Q2 | $361K | Hold |
976
| – | – | ﹤0.01% | 352 |
|
|
2021
Q1 | $283K | Buy |
+976
| New | +$283K | ﹤0.01% | 368 |
|